The toxicology division at Aprofood carries out comprehensive 90-day subchronic oral safety evaluations for raw pollen, wall-broken pollen, extracts, and retail products. Regular daily ingestion represents the actual consumption pattern of peony pollen products, making this extended trial essential for verifying long-term dietary suitability. Our reports clearly define physiological target organs, dose response dynamics, and the precise no observed adverse effect level (NOAEL), offering product developers a dependable safety foundation for regulatory filings, novel ingredient approval, and commercial distribution.
Repeated dose testing measures the biological response to daily oral exposure over three months, revealing cumulative effects on organ tissue, blood parameters, and growth trajectories that single dose acute tests cannot detect. Because wall-broken pollen and concentrated extracts contain elevated levels of active compounds like flavonoids compared to raw pollen, long term traditional use alone cannot prove their safety. Standardized 90-day subchronic studies are therefore required by regulatory agencies to identify target organs, calculate the NOAEL, and ensure long term daily consumption presents no health risks. Dose levels are set to bracket the intended human intake, and the dose-response data show at which level, if any, adverse effects begin to appear. The NOAEL obtained in this way is the basis for deriving a recommended daily intake, which allows developers to set label directions and maximum use levels with confidence.
With deep expertise in safety evaluation, the scientific team at Aprofood conducts rigorous toxicological studies designed to satisfy global regulatory frameworks and quality standards. Following OECD Guideline 408 along with relevant national food safety protocols, each trial design is individually tailored to match the test article physical properties, expected human intake, and specific regional regulatory targets. We utilize the following methodological framework to assess the subchronic safety profile of peony pollen products.
| Test Method | Description |
|---|---|
| 90-Day Repeated Dose Oral Toxicity Study in Rodents |
|
| Clinical Observation & Body Weight Monitoring |
|
| Hematology & Clinical Chemistry |
|
| Ophthalmology & Functional Observations |
|
| Gross Necropsy & Organ Weights |
|
| Histopathology |
|
Aprofood matches each 90-day study design to the purpose at hand, because repeated-dose safety data are needed at several points between product development and market entry. During development, the results show whether a new peony pollen ingredient or formulation causes cumulative effects that a single-dose test would miss. Closer to launch, the same data support safety dossiers and the setting of recommended daily intake, and they help demonstrate to regulators that long-term consumption is safe. Typical applications are listed below.
| Application | Description |
|---|---|
| Pollen Long-Term Safety Evaluation | Assessment of raw and wall-broken pollen intended for daily consumption, confirming the absence of cumulative toxicity. |
| Extract Assessment | Evaluation of extracts and concentrated ingredients whose composition and active compound levels differ from raw pollen. |
| Novel Food Registration | Repeated-dose toxicity data and a NOAEL required in safety dossiers, which can be planned together with acute, genetic toxicity and reproductive studies around the regulatory pathway of your target market. |
| Safe Use Level Setting | Dose-response data and a NOAEL used to derive recommended daily intake and maximum use levels. |
| Finished Product Verification | Testing of tablets, capsules, powders and beverages as marketed, with the dosing formulation adapted to each product form. |
We review the test material, intended use, target market, and study objectives, then develop a study protocol and quotation for confirmation. The protocol specifies dose levels, animal numbers, study duration, and applicable guidelines.
The test material is characterized and prepared into a suitable dosing formulation. Homogeneity and stability are assessed to ensure consistent and representative dosing throughout the study.
Healthy animals are acclimated under controlled laboratory conditions before dosing. Temperature, humidity, lighting, diet, housing, and general health are monitored throughout the acclimation period.
Animals receive the test material by oral gavage at the specified dose levels and are monitored throughout the study period. Clinical signs, behavior, food intake, body weight, and other relevant observations are recorded at scheduled intervals.
Gross necropsy is performed at study completion, with histopathological evaluation conducted when required. Study data are analyzed to identify treatment-related findings and assess overall toxicity.
A comprehensive report summarizes study procedures, observations, toxicity findings, and conclusions. Raw data and recommendations for further safety or toxicological studies are provided where applicable.
We know how wall-breaking and extraction change the composition of peony pollen products, and design dosing and test plans accordingly.
Studies follow OECD guidelines and national food safety standards, so the data suit regulatory submissions in different markets.
Limit tests and stepwise procedures are selected where appropriate, meeting ethical requirements while saving time and cost.
Results link directly to genetic toxicity, reproductive toxicity and 90-day subchronic studies, so a complete safety evaluation can be planned in one project.
Our scientists have extensive experience in study design, data interpretation and safety assessment, and can explain the results clearly in the context of your product and market.
Each report includes the protocol, raw data, observations and conclusions, giving you well-documented results that are ready for technical files and regulatory dossiers.
Q1: Which forms of peony pollen can go into a 90-day study?
Q2: Is gavage or dietary dosing better for my product?
Q3: How much sample do I need to send?
Q4: How long before the final report is ready?
Q5: What does the NOAEL tell me?
Q6: Can the 90-day study run alongside other safety studies?
From study design to final reporting, Aprofood provides a structured approach to evaluating the long-term safety of peony pollen products and supporting regulatory submissions. The study strategy takes into account the specific product form, target market, and applicable regulatory pathway, with study data organized to support the intended dossier. Repeated-dose toxicity findings are carefully documented and interpreted to clarify their regulatory significance and inform subsequent safety studies. For project planning and study support, please contact us.
Thank you for visiting Aprofood Food Ingredients. If you are interested in our products/services/solutions and would like to seek cooperation, please leave your message.
Contact UsWe are more than a food ingredient and additive provider. We are a reliable, end-to-end, innovation-driven partner powered by science and experts.